Treatment of hairy cell leukaemia with recombinant alpha-interferon

W. R. Bezwoda, C. S. Hesdorffer, R. D. Dansey, D. Lewis

Research output: Contribution to journalArticlepeer-review

Abstract

Of 10 patients with hairy cell leukaemia treated with 3 mU recombinant α-interferon daily, 9 showed clinical and haematological response - including 2 patients who achieved complete remission. Unmaintained responses have continued for as long as 18+ months after completion of therapy. There was no significant toxicity associated with this treatment schedule.

Original languageEnglish (US)
Pages (from-to)661-662
Number of pages2
JournalSouth African Medical Journal
Volume72
Issue number10
StatePublished - Dec 1 1987

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Treatment of hairy cell leukaemia with recombinant alpha-interferon'. Together they form a unique fingerprint.

Cite this